Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
British Journal of Cancer|March 1, 1976
Anti-tumour and anti-metastatic activity of 3-(P-Chlorophenyl)-2,3-Dihydro-3-Hydroxythiazolo (3,2-A)-Benzimidazole-2-acetic acid (WY-13,876)R L Fenichel, F J Gregory, H E AlburnJournal of Immunopharmacology|January 1, 1980
Immunomodulating and antimetastatic activity of 3-(p-chlorophenyl) thiazolo[3,2-a]benzimidazole-2-acetic acid (Wy-18,251, NSC 310633)R L Fenichel, H E Alburn, P A Schreck, et al.Thrombosis Research|June 1, 1994
Analysis of the potassium channel openers celikalim, pinacidil and cromakalim in platelet models of thrombosisD M Patelunas-Hoffman, W J Carmint, T J Colatsky, et al.Thrombosis Research|June 1, 1991
Comparative antithrombotic activities of the phosphodiesterase inhibitors pelrinone (AY-26,768), AY-31,390 and milrinoneD M Patelunas, W J Carmint, J Z Willis, et al.Journal of Immunopharmacology|January 1, 1983
Immunomodulating activity of 3-(p-chlorophenyl)thiazolo-[3,2-a] benzimidazole-2-acetic acid (Wy-18,251, NSC 310633) in mice implanted with Lewis lung tumor. Effect of Wy-18,251 on lymphocyte proliferation and phagocytosisR L Fenichel, S K Dheer, N H Grant, et al.Pageof 1